Page last updated: 2024-08-26

nortrachelogenin and Prostatic Neoplasms

nortrachelogenin has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eklund, P; Eriksson, JE; Holmbom, T; Paul, P; Peuhu, E; Remes, M; Sjöholm, R1
Aittokallio, T; Eckerman, C; Holmbom, B; Laajala, TD; Mäkelä, SI; Polari, L; Saarinen, NM; Smeds, A; Yatkin, E1

Other Studies

2 other study(ies) available for nortrachelogenin and Prostatic Neoplasms

ArticleYear
The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling.
    Biochemical pharmacology, 2013, Sep-01, Volume: 86, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Furans; Humans; Insulin-Like Growth Factor I; Lignans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand

2013
Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Furans; Heterografts; Humans; Lignans; Male; Mice; Pinus sylvestris; Plant Extracts; Prostatic Neoplasms; Stilbenes; TNF-Related Apoptosis-Inducing Ligand

2014